WallStreetZenWallStreetZen

Sectors & IndustriesHealthcareBiotechnology
Best Biotech Stocks to Buy Now (2024)
Top biotech stocks in 2024 ranked by overall Zen Score. See the best biotech stocks to buy now, according to analyst forecasts for the biotechnology industry.

Industry: Biotechnology
Ticker
Company
Price
Valuation Score
Graham Fair Value
Graham Fair Value %
P/E
Forward P/E
P/S
P/B
PEG
Free Cash Flow
Free Cash Flow Yield
Book Value
BVPS
EV
EV/EBITDA
SYRS
SYROS PHARMACEUTICALS INC
$5.13N/AN/A-0.88x-0.55x14.62x8.14xN/A-$108.42M-74.62%$16.66M0.59$56.14M-0.36
LRMR
LARIMAR THERAPEUTICS INC
$7.77N/AN/A-9.24x-5.21xN/A6.06xN/A-$33.62M-9.86%$81.72M1.86$472.87M-12.91
MNOV
MEDICINOVA INC
$1.31N/AN/A-7.71x-3.36x65.50x1.03xN/A-$7.45M-11.60%$62.38M1.27$13.47M-1.61
SLNO
SOLENO THERAPEUTICS INC
$45.12N/AN/A-19.12x-300.80xN/A9.30xN/A-$24.94M-3.35%$157.51M9.55$1.30B-35.29
ERAS
ERASCA INC
$2.14N/AN/A-2.58x-1.22xN/A1.02xN/A-$102.99M-32.06%$316.69M2.11$286.57M-2.36
VRNA
VERONA PHARMA PLC
$15.69N/AN/A-21.79x-35.66xN/A5.09xN/A-$50.22M-4.04%$249.28M3.15$1.05B-20.48
QNCX
QUINCE THERAPEUTICS INC
$0.99N/AN/A-1.17x-0.31xN/A0.50xN/A-$18.36M-50.05%$85.08M2.29$35.57M-1.14
CNTB
CONNECT BIOPHARMA HOLDINGS LTD
$1.59N/AN/A-1.47x-0.70xN/A0.87xN/A-$45.28M-51.70%$101.04M1.83-$17.93M0.30
VOR
VOR BIOPHARMA INC
$1.80N/AN/A-1.03x-0.85xN/A0.81xN/A-$101.36M-83.83%$150.72M2.24$124.59M-1.14
ABOS
ACUMEN PHARMACEUTICALS INC
$3.49N/AN/A-3.23x-3.03xN/A0.79xN/A-$43.08M-25.39%$266.97M5.49$173.61M-3.36
THRD
THIRD HARMONIC BIO INC
$11.70N/AN/A-15.00xN/AN/A1.77xN/A-$20.59M-4.44%$269.09M6.79$210.79M-6.97
BCRX
BIOCRYST PHARMACEUTICALS INC
$4.45N/AN/A-3.77x-27.81x2.58x-2.01xN/A-$97.31M-11.37%-$455.53M-2.37$1.65B-14.21
MACK
MERRIMACK PHARMACEUTICALS INC
$15.00N/AN/A-187.50xN/AN/A11.61xN/A-$1.52M-0.71%$18.75M1.31$211.75M-181.14
TNGX
TANGO THERAPEUTICS INC
$7.61N/AN/A-7.05x-3.51x19.72x3.21xN/A-$119.51M-16.61%$253.11M2.68$783.81M-8.20
RGNX
REGENXBIO INC
$16.83N/AN/A-2.80x-5.24x8.16x2.40xN/A-$228.37M-31.03%$311.74M7.13$800.45M-3.34
ONVO
ORGANOVO HOLDINGS INC
$1.03N/AN/A-0.47xN/A38.15x1.67xN/A-$16.92M-180.19%$6.18M0.68$6.40M-0.34
NTRB
NUTRIBAND INC
$3.49N/AN/A-5.06xN/A13.32x5.95xN/A-$3.58M-12.89%$6.44M0.81$38.03M-7.47
MTNB
MATINAS BIOPHARMA HOLDINGS INC
$0.18N/AN/A-1.59xN/A35.00x1.98xN/A-$15.50M-40.57%$19.25M0.09$36.83M-1.67
CTMX
CYTOMX THERAPEUTICS INC
$4.43N/AN/A-443.00x-8.36x3.23x-6.32xN/A-$56.88M-17.40%-$47.45M-0.64$295.89M32.07
AFMD
AFFIMED NV
$5.42N/AN/A-0.70x-0.90x9.00x1.31xN/A-$123.91M-153.01%$62.83M4.21$61.69M-0.54
APLS
APELLIS PHARMACEUTICALS INC
$47.46N/AN/A-10.67x-75.33x14.20x29.42xN/A-$595.41M-10.57%$194.52M1.64$5.48B-11.07
GNLX
GENELUX CORP
$3.83N/AN/A-3.30xN/A547.14x5.28xN/A-$21.30M-22.77%$19.47M0.80$95.34M-3.45
RCUS
ARCUS BIOSCIENCES INC
$15.70N/AN/A-3.78x-3.92x9.93x3.09xN/A-$330.00M-28.40%$462.00M6.24$1.30B-4.56
SCPH
SCPHARMACEUTICALS INC
$4.66N/AN/A-3.28x-4.24x13.20x4.51xN/A-$59.28M-33.03%$37.22M0.97$161.47M-3.51
INMB
INMUNE BIO INC
$11.57N/AN/A-6.93x-5.64x1,285.56x5.59xN/A-$11.98M-5.76%$37.34M2.08$183.16M-6.10
ORGS
ORGENESIS INC
$0.53$11.42-95.39%0.28xN/A29.28x-0.86x0.20x-$16.93M-110.82%-$20.98M-0.72$39.24M-0.77
PRAX
PRAXIS PRECISION MEDICINES INC
$54.54N/AN/A-2.92x-1.29x147.01x10.36xN/A-$111.19M-30.91%$69.67M10.57$643.21M-5.27
FTRE
FORTREA HOLDINGS INC
$37.41N/AN/A-935.25xN/A1.08x1.92xN/A$135.60M4.06%$1.74B19.45$4.91B25.24
ELAB
ELEVAI LABS INC
$0.70N/AN/A-1.75xN/A4.41x3.17xN/A-$4.57M-60.63%$3.83M0.36$9.03M-2.11
PHAT
PHATHOM PHARMACEUTICALS INC
$10.04N/AN/A-2.55x-2.96x772.31x-8.07xN/A-$139.21M-27.03%-$72.76M-1.42$641.70M-4.03
LEXX
LEXARIA BIOSCIENCE CORP
$3.13N/AN/A-4.60x-3.60x86.94x6.19xN/A-$5.21M-15.46%$6.52M0.61$35.78M-6.83
FBIO
FORTRESS BIOTECH INC
$1.75N/AN/A-0.21x0.08x0.17x1.49xN/A-$122.29M-861.54%$22.54M2.78$35.89M-0.98
SYBX
SYNLOGIC INC
$1.84N/AN/A-0.21x-0.18x3.55x0.50xN/A-$51.81M-433.04%$42.66M6.56$13.65M-0.26
MGX
METAGENOMI INC
$6.32N/AN/A-0.32xN/A0.48x-1.75xN/A-$101.22M-470.43%-$135.58M-39.82$139.20M-2.69
CDXC
CHROMADEX CORP
$3.78N/AN/A-54.00x-63.00x3.39x10.00xN/A$6.97M2.46%$28.46M0.38$260.62M-80.61
OABI
OMNIAB INC
$4.67N/AN/A-9.16xN/A13.62x1.74xN/A$703.00k0.15%$314.59M3.16$555.62M-12.38
ADAP
ADAPTIMMUNE THERAPEUTICS PLC
$1.19N/AN/A-2.20x-0.92x3.97x7.45xN/A-$145.56M-60.84%$39.51M0.20$172.53M-1.68
AUTL
AUTOLUS THERAPEUTICS PLC
$4.19N/AN/A-3.49x-3.49x419.00x10.00xN/A-$156.57M-21.48%$111.47M0.64$1.10B-7.19
IBRX
IMMUNITYBIO INC
$9.15N/AN/A-7.96x-11.58x9,150.00x-10.51xN/A-$397.34M-8.54%-$586.99M-1.15$6.78B-15.80
HRTX
HERON THERAPEUTICS INC
$2.61N/AN/A-3.26x-52.20x2.84x-11.55xN/A-$60.32M-16.74%-$33.97M-0.25$543.31M-5.07
PRQR
PROQR THERAPEUTICS NV
$2.01N/AN/A-5.29x-2.87x15.70x3.63xN/A$30.63M18.81%$44.99M0.56$55.71M-2.12
RLMD
RELMADA THERAPEUTICS INC
$3.68N/AN/A-1.12x-0.91xN/A1.30xN/A-$51.66M-46.63%$85.36M2.84$106.95M-1.08
MURA
MURAL ONCOLOGY PLC
$3.83N/AN/A-0.31xN/AN/A0.25xN/A-$197.70M-309.30%$263.82M15.81-$191.29M0.99
ADTX
ADITXT INC
$2.30N/AN/A-0.02x0.00x1.08x0.24xN/A-$18.59M-2,673.39%$16.06M53.10$21.84M-0.79
HEPA
HEPION PHARMACEUTICALS INC
$1.46N/AN/A-0.12x-0.11xN/A1.10xN/A-$40.90M-705.55%$7.28M1.83-$6.59M0.13
OLMA
OLEMA PHARMACEUTICALS INC
$10.67N/AN/A-4.99x-3.39xN/A2.35xN/A-$83.71M-17.34%$253.90M5.61$530.49M-5.59
IVVD
INVIVYD INC
$2.42N/AN/A-1.34x-3.18xN/A1.63xN/A-$173.78M-65.58%$177.47M1.62$90.04M-0.46
ATXI
AVENUE THERAPEUTICS INC
$4.78N/AN/A-0.07xN/AN/A1.78xN/A-$9.45M-1,400.06%$1.58M11.20$1.04M-0.10
GOVX
GEOVAX LABS INC
$1.61N/AN/A-0.11xN/AN/A0.61xN/A-$25.22M-862.05%$5.76M3.17-$2.96M0.11
LXEO
LEXEO THERAPEUTICS INC
$12.77N/AN/A-1.03xN/AN/A3.00xN/A-$59.61M-87.18%$113.54M21.20$227.48M-3.54
GLTO
GALECTO INC
$0.70N/AN/A-0.61x-0.29xN/A0.67xN/A-$33.63M-177.14%$28.16M1.04-$2.11M0.07
CARM
CARISMA THERAPEUTICS INC
$1.62N/AN/A-0.63xN/A3.64x2.54xN/A-$82.31M-151.54%$26.53M0.79-$7.18M0.09
SGMT
SAGIMET BIOSCIENCES INC
$4.32N/AN/A-1.62xN/A22.62x1.51xN/A-$23.77M-52.59%$91.07M8.71$62.79M-2.26
SLRN
ACELYRIN INC
$4.35N/AN/A-0.80xN/AN/A0.65xN/A-$172.00M-56.28%$656.34M9.34$210.98M-0.55
MIRA
MIRA PHARMACEUTICALS INC
$0.73N/AN/A-1.15xN/AN/A2.48xN/A-$4.53M-33.29%$4.37M0.24$6.24M-0.73
SRZN
SURROZEN INC
$10.00N/AN/A-0.47x-0.52xN/A0.84xN/A-$40.76M-201.99%$37.94M18.80-$1.36M0.03
THTX
THERATECHNOLOGIES INC
$1.28N/AN/A-3.11x4.00x1.02x-3.25xN/A-$3.05M-5.16%-$18.09M-0.39$78.63M-55.61
IMRX
IMMUNEERING CORP
$1.64N/AN/A-0.87x-0.69xN/A0.53xN/A-$49.31M-105.79%$90.58M3.19-$6.92M0.13
RNAC
CARTESIAN THERAPEUTICS INC
$25.60N/AN/A-0.51x-10.67x5.09x-0.31xN/A-$51.37M-38.81%-$440.18M-85.14$72.24M-0.31
INZY
INOZYME PHARMA INC
$4.74N/AN/A-3.46x-2.74xN/A2.08xN/A-$70.97M-28.88%$140.48M2.71$304.49M-4.58
ALXO
ALX ONCOLOGY HOLDINGS INC
$15.36N/AN/A-4.11x-4.35xN/A4.06xN/A-$131.64M-19.93%$189.71M4.41$757.57M-4.78
EWTX
EDGEWISE THERAPEUTICS INC
$19.52N/AN/A-12.43x-8.87xN/A5.70xN/A-$97.69M-7.85%$318.83M5.00$1.74B-17.65
XERS
XERIS BIOPHARMA HOLDINGS INC
$1.89N/AN/A-4.20x-8.22x1.59x-39.14xN/A-$49.29M-18.94%-$6.78M-0.05$427.20M-18.00
IRON
DISC MEDICINE INC
$29.79N/AN/A-8.71x-4.80xN/A2.13xN/A-$73.55M-11.06%$345.12M15.47$376.97M-4.96
IMVT
IMMUNOVANT INC
$28.86N/AN/A-15.77x-14.01xN/A6.17xN/A-$210.56M-5.05%$679.34M4.70$3.50B-14.43
FBRX
FORTE BIOSCIENCES INC
$0.71N/AN/A-0.71xN/AN/A0.74xN/A-$28.79M-127.73%$35.31M1.12-$11.14M0.35
ONCT
ONCTERNAL THERAPEUTICS INC
$8.75N/AN/A-0.65x-0.51x32.75x0.86xN/A-$32.16M-125.10%$30.05M10.22$19.50M-0.50
TSBX
TURNSTONE BIOLOGICS CORP
$2.72N/AN/A-0.57xN/A1.63x0.64xN/A-$66.95M-212.87%$98.67M8.53$48.13M-0.91
DRTS
ALPHA TAU MEDICAL LTD
$2.49N/AN/A-5.93x-3.95xN/A2.05xN/A-$24.36M-14.10%$84.48M1.22$174.10M-8.09
APVO
APTEVO THERAPEUTICS INC
$0.99N/AN/A-0.02xN/AN/A0.04xN/A-$11.73M-4,265.42%$12.22M43.95-$10.98M0.65
RCKT
ROCKET PHARMACEUTICALS INC
$23.47N/AN/A-8.04x-8.04xN/A4.31xN/A-$211.39M-10.72%$492.57M5.86$2.09B-8.84
VIGL
VIGIL NEUROSCIENCE INC
$3.03N/AN/A-1.42x-0.92xN/A0.96xN/A-$71.04M-60.56%$116.25M3.00$72.69M-0.90
NNVC
NANOVIRICIDES INC
$1.13N/AN/A-1.40xN/AN/A1.07xN/A-$6.20M-46.73%$12.45M1.06$8.06M-0.94
RAPT
RAPT THERAPEUTICS INC
$8.33N/AN/A-2.73x-2.11xN/A1.97xN/A-$98.17M-30.74%$147.04M3.84$249.29M-2.20
VRPX
VIRPAX PHARMACEUTICALS INC
$2.24N/AN/A-0.17xN/AN/A1.36xN/A-$9.85M-375.58%$1.93M1.65-$6.52M0.43
REPL
REPLIMUNE GROUP INC
$6.95N/AN/A-2.20x-2.36xN/A1.01xN/A-$176.27M-38.06%$421.54M6.33$403.15M-2.01
TRML
TOURMALINE BIO INC
$15.84N/AN/A-1.79x-1.03xN/A1.98xN/A-$28.14M-37.42%$205.04M43.19$265.70M-6.33
LBPH
LONGBOARD PHARMACEUTICALS INC
$21.38N/AN/A-9.54x-10.38xN/A2.65xN/A-$52.95M-7.01%$313.71M8.88$780.65M-13.47
MLTX
MOONLAKE IMMUNOTHERAPEUTICS
$45.26N/AN/A-62.00x-34.03xN/A5.83xN/A-$43.06M-1.94%$495.68M10.09$2.44B-55.58
COGT
COGENT BIOSCIENCES INC
$7.53N/AN/A-3.11x-3.73xN/A3.04xN/A-$156.42M-26.08%$257.80M3.24$748.09M-3.96
RZLT
REZOLUTE INC
$3.31N/AN/A-3.01x-1.22xN/A1.43xN/A-$53.00M-31.15%$91.73M1.78$121.17M-2.15
CRVS
CORVUS PHARMACEUTICALS INC
$1.92N/AN/A-3.43x-1.24xN/A2.43xN/A-$23.97M-25.99%$38.68M0.81$82.91M-3.08
ZURA
ZURA BIO LTD
$4.62N/AN/A-2.21xN/AN/A3.39xN/A-$15.05M-9.85%$59.33M1.79$101.60M-1.68
ATHE
ALTERITY THERAPEUTICS LTD
$2.05N/AN/A-0.92xN/AN/A1.00xN/A-$9.55M-99.71%$11.52M2.47$3.44MN/A
SRRK
SCHOLAR ROCK HOLDING CORP
$15.35N/AN/A-7.71x-5.79xN/A5.31xN/A-$145.28M-11.36%$225.22M2.70$1.15B-7.40
CRGX
CARGO THERAPEUTICS INC
$20.33N/AN/A-1.23xN/AN/A1.97xN/A-$89.44M-74.08%$405.39M68.26$422.49M-4.55
SNTI
SENTI BIOSCIENCES INC
$0.37N/AN/A-0.23xN/A6.38x0.25xN/A-$64.33M-391.89%$66.91M1.51$15.15M-0.23
ADCT
ADC THERAPEUTICS SA
$4.90N/AN/A-1.67x-2.71x5.76x-2.73xN/A-$121.90M-30.45%-$148.25M-1.81$250.17M-1.65
ELDN
ELEDON PHARMACEUTICALS INC
$2.41N/AN/A-1.47x-0.83xN/A0.72xN/A-$39.53M-66.64%$83.42M3.39$55.57M-1.39
ACHL
ACHILLES THERAPEUTICS PLC
$0.80N/AN/A-0.46x-0.40xN/A0.23xN/A-$49.55M-154.23%$142.37M3.56-$93.89M1.46
GOSS
GOSSAMER BIO INC
$0.74N/AN/A-0.63x-0.34xN/A2.66xN/A-$159.16M-140.95%$62.77M0.41$343.98M-2.12
INTS
INTENSITY THERAPEUTICS INC
$3.86N/AN/A-2.80xN/AN/A4.02xN/A-$7.21M-21.66%$13.16M1.53$44.50M-4.41
ALVR
ALLOVIR INC
$0.80N/AN/A-0.44x-0.36xN/A0.63xN/A-$124.45M-149.87%$145.78M1.40$28.12M-0.15
NMRA
NEUMORA THERAPEUTICS INC
$9.25N/AN/A-2.55xN/AN/A3.13xN/A-$163.40M-27.17%$469.08M7.21$1.10B-4.75
COYA
COYA THERAPEUTICS INC
$8.68N/AN/A-10.99xN/A14.69x3.54xN/A-$11.19M-12.68%$35.64M3.51$93.60M-12.93
TCBP
TC BIOPHARM (HOLDINGS) PLC
$1.46N/AN/A-0.06xN/AN/A1.36xN/A-$13.66M-3,028.84%$3.44M11.14$3.82M-0.47
TCON
TRACON PHARMACEUTICALS INC
$1.86N/AN/A-0.85x-0.08x0.25x-5.23xN/A$3.68M120.70%-$809.00k-0.49-$4.41M-1.17
ENTA
ENANTA PHARMACEUTICALS INC
$15.17N/AN/A-2.31x3.55x4.35x1.67xN/A-$99.19M-31.01%$191.88M9.10$302.53M-2.42
ACRV
ACRIVON THERAPEUTICS INC
$9.59N/AN/A-3.50xN/AN/A1.79xN/A-$43.93M-20.75%$121.20M5.49$185.30M-3.14
TENX
TENAX THERAPEUTICS INC
$3.84N/AN/A-0.12x-0.01xN/A0.93xN/A-$5.90M-618.49%$8.10M32.60-$1.77M0.23

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in May 2024?

According to Zen Score, the 3 best biotechnology stocks to buy right now are:

1. Corcept Therapeutics (NASDAQ:CORT)


Corcept Therapeutics (NASDAQ:CORT) is the top biotech stock with a Zen Score of 65, which is 42 points higher than the biotech industry average of 23. It passed 21 out of 33 due diligence checks and has strong fundamentals. Corcept Therapeutics has seen its stock return 6.15% over the past year, overperforming other biotech stocks by 24 percentage points.

Corcept Therapeutics has an average 1 year price target of $40.67, an upside of 65.85% from Corcept Therapeutics's current stock price of $24.52.

Corcept Therapeutics stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Corcept Therapeutics, 66.67% have issued a Strong Buy rating, 33.33% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Incyte (NASDAQ:INCY)


Incyte (NASDAQ:INCY) is the second best biotech stock with a Zen Score of 64, which is 41 points higher than the biotech industry average of 23. It passed 20 out of 33 due diligence checks and has strong fundamentals. Incyte has seen its stock lose -20.99% over the past year, underperforming other biotech stocks by -3 percentage points.

Incyte has an average 1 year price target of $74.92, an upside of 39.37% from Incyte's current stock price of $53.76.

Incyte stock has a consensus Buy recommendation according to Wall Street analysts. Of the 13 analysts covering Incyte, 30.77% have issued a Strong Buy rating, 23.08% have issued a Buy, 46.15% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Amylyx Pharmaceuticals (NASDAQ:AMLX)


Amylyx Pharmaceuticals (NASDAQ:AMLX) is the third best biotech stock with a Zen Score of 63, which is 40 points higher than the biotech industry average of 23. It passed 20 out of 33 due diligence checks and has strong fundamentals. Amylyx Pharmaceuticals has seen its stock lose -92.77% over the past year, underperforming other biotech stocks by -74 percentage points.

Amylyx Pharmaceuticals has an average 1 year price target of $11.00, an upside of 441.87% from Amylyx Pharmaceuticals's current stock price of $2.03.

Amylyx Pharmaceuticals stock has a consensus Buy recommendation according to Wall Street analysts. Of the 5 analysts covering Amylyx Pharmaceuticals, 40% have issued a Strong Buy rating, 20% have issued a Buy, 40% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 3 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Mei Pharma (NASDAQ:MEIP)


Mei Pharma (NASDAQ:MEIP) has an annual dividend yield of 57.19%, which is 42 percentage points higher than the biotech industry average of 15.03%.

Mei Pharma's dividend payout ratio of 58.9% indicates that its high dividend yield is sustainable for the long-term.

2. Novo Nordisk A S (NYSE:NVO)


Novo Nordisk A S (NYSE:NVO) has an annual dividend yield of 1.11%, which is -14 percentage points lower than the biotech industry average of 15.03%. Novo Nordisk A S's dividend payout is not stable, having dropped more than 10% nine times in the last 10 years. Novo Nordisk A S's dividend has shown consistent growth over the last 10 years.

Novo Nordisk A S's dividend payout ratio of 47.8% indicates that its dividend yield is sustainable for the long-term.

3. Bio Techne (NASDAQ:TECH)


Bio Techne (NASDAQ:TECH) has an annual dividend yield of 0.41%, which is -15 percentage points lower than the biotech industry average of 15.03%. Bio Techne's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Bio Techne's dividend has shown consistent growth over the last 10 years.

Bio Techne's dividend payout ratio of 22.7% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks up?

Biotech stocks were up 1.07% in the last day, and up 6% over the last week. Ardelyx was the among the top gainers in the biotechnology industry, gaining 28.42% yesterday.

Ardelyx shares are trading higher after the company reported better-than-expected Q1 financial results.

What are the most undervalued biotech stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued biotech stocks right now are:

1. Incyte (NASDAQ:INCY)


Incyte (NASDAQ:INCY) is the most undervalued biotech stock based on WallStreetZen's Valuation Score. Incyte has a valuation score of 86, which is 73 points higher than the biotech industry average of 13. It passed 6 out of 7 valuation due diligence checks.

Incyte's stock has dropped -20.99% in the past year. It has underperformed other stocks in the biotech industry by -3 percentage points.

2. Royalty Pharma (NASDAQ:RPRX)


Royalty Pharma (NASDAQ:RPRX) is the second most undervalued biotech stock based on WallStreetZen's Valuation Score. Royalty Pharma has a valuation score of 86, which is 73 points higher than the biotech industry average of 13. It passed 6 out of 7 valuation due diligence checks.

Royalty Pharma's stock has dropped -19.61% in the past year. It has underperformed other stocks in the biotech industry by -1 percentage points.

3. Amylyx Pharmaceuticals (NASDAQ:AMLX)


Amylyx Pharmaceuticals (NASDAQ:AMLX) is the third most undervalued biotech stock based on WallStreetZen's Valuation Score. Amylyx Pharmaceuticals has a valuation score of 71, which is 58 points higher than the biotech industry average of 13. It passed 5 out of 7 valuation due diligence checks.

Amylyx Pharmaceuticals's stock has dropped -92.77% in the past year. It has underperformed other stocks in the biotech industry by -74 percentage points.

Are biotech stocks a good buy now?

50.1% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 80.46% over the next year.

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is 6.05x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.